Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 5,090.00
-110.00 (-2.12%)
At close: Aug 21, 2026
Dongwha Pharm.Co.,Ltd Market Cap
Dongwha Pharm.Co.,Ltd has a market cap or net worth of 141.08 billion as of August 21, 2026. Its market cap has decreased by -19.72% in one year.
Market Cap
141.08B
Enterprise Value
252.82B
Revenue
513.24B
Ranking
n/a
PE Ratio
7.80
Stock Price
5,090.00
ChartMarket Cap Chart
Since August 28, 1995, Dongwha Pharm.Co.,Ltd's market cap has increased from 72.32B to 141.08B, an increase of 95.07%. That is a compound annual growth rate of 2.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 141.08B | -18.56% |
| Dec 30, 2025 | 173.24B | -0.79% |
| Dec 30, 2024 | 174.62B | -38.57% |
| Dec 28, 2023 | 284.26B | 10.91% |
| Dec 29, 2022 | 256.31B | -36.58% |
| Dec 30, 2021 | 404.12B | -25.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daewon Pharmaceutical | 167.40B |
| Hyundai Pharmaceutical | 161.91B |
| Daihan Pharmaceutical | 156.41B |
| Hana Pharm | 150.18B |
| Ilyang Pharmaceutical Co.,Ltd | 148.78B |
| Dong Sung Bio Pharm.Co.,Ltd. | 145.99B |
| Jeil Pharmaceutical Co.,Ltd | 144.11B |
| Ilsung Is | 142.86B |